R&D Partner Content 5th Supply Chain & Logistics for Cell Therapies Summit Uniting Supply Chain & Clinical Operation Leaders
R&D Partner Content 5th TCR-based Therapies for Solid Tumors Summit Advancing TCR-based Cell Therapies & Bispecific Approaches
R&D Partner Content Biophysics for Drug Discovery Summit Advance Biophysics Technologies & Applications to Measure Molecular & Target Interactions
R&D Partner Content Polymer Chemistry & Formulation in Drug Delivery Design Your Novel Polymers & Maximize Payload Compatibility for Sustained & Controlled Release
R&D Partner Content 5th Gene Therapy Analytical Development Europe Summit return... Develop, Validate and Implement Analytical Tools for Complex Gene Therapies
R&D Partner Content 7th Gene Therapy for Rare Disorders Summit returns to Boston... Accelerating Safe, Effective & Accessible Therapies in Rare Diseases
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.